|
G2E3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.87760004502991E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.47680004178608E-10 |
| Normal-vs-Stage2 |
2.04899999999286E-05 |
| Normal-vs-Stage3 |
1.584200E-02 |
| Normal-vs-Stage4 |
6.895500E-03 |
| Stage1-vs-Stage2 |
6.618400E-01 |
| Stage1-vs-Stage3 |
5.060100E-02 |
| Stage1-vs-Stage4 |
2.412400E-01 |
| Stage2-vs-Stage3 |
2.762000E-01 |
| Stage2-vs-Stage4 |
3.838400E-01 |
| Stage3-vs-Stage4 |
8.909800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.28370003305412E-09 |
| Normal-vs-AfricanAmerican |
3.15740000034204E-07 |
| Normal-vs-Asian |
1.006830E-01 |
| Caucasian-vs-AfricanAmerican |
7.942400E-01 |
| Caucasian-vs-Asian |
3.818200E-01 |
| AfricanAmerican-vs-Asian |
2.614600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.3951999251799E-10 |
| Normal-vs-Female |
7.162600E-03 |
| Male-vs-Female |
3.962400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.40910000001604E-06 |
| Normal-vs-Extreme_Weight |
2.38760011761485E-10 |
| Normal-vs-Obese |
9.820100000002E-05 |
| Normal-vs-Extreme_Obese |
9.2937999995879E-07 |
| Normal_Weight-vs-Extreme_Weight |
2.727200E-01 |
| Normal_Weight-vs-Obese |
5.060600E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.407000E-01 |
| Extreme_Weight-vs-Obese |
6.981800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.831400E-01 |
| Obese-vs-Extreme_Obese |
5.564400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.427600E-01 |
| Normal-vs-Age(41-60Yrs) |
4.26419999977057E-07 |
| Normal-vs-Age(61-80Yrs) |
1.24939947276914E-10 |
| Normal-vs-Age(81-100Yrs) |
6.23889999995519E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.335000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.610400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.413600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.286400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.174610E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.478200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.02020014237337E-10 |
| Normal-VS-Type2 PRCC |
1.5008000397998E-09 |
| Normal-VS-KIRP CIMP |
6.961800E-01 |
| Normal-VS-Unclassified PRCC |
6.184500E-04 |
| Type1 PRCC-VS-Type2 PRCC |
5.017800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.913900E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.946200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.509700E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.167200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.441360E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.54299914459466E-11 |
| Normal-vs-N1 |
5.941800E-01 |
| Normal-vs-N2 |
5.51489999999211E-05 |
| N0-vs-N1 |
8.015000E-03 |
| N0-vs-N2 |
2.657400E-01 |
| N1-vs-N2 |
1.041180E-01 |
|
|
